| 发明名称 |
Use of AT-1 receptor antagonist or treating diseases associated with an increase of AT-1 receptor |
| 摘要 |
Use of an AT1 (angiotensin) receptor antagonist for producing a pharmaceutical preparation for treating invasive lung cancer or invasive breast cancer. An AT1 receptor antagonist is selected from formula (a) to (k), and the compound valsartan.
|
| 申请公布号 |
NZ511938(A) |
申请公布日期 |
2004.02.27 |
| 申请号 |
NZ19990511938 |
申请日期 |
1999.12.22 |
| 申请人 |
NOVARTIS AG |
发明人 |
BULLOCK, GILLIAN ROSEMARY;DE GASPARO, MARC;GANTER,SABINA MARIA |
| 分类号 |
A61K9/20;A61K9/28;A61K31/00;A61K31/41;A61K31/415;A61K31/4178;A61K31/4188;A61K31/437;A61K31/44;A61K31/4439;A61K31/455;A61K45/00;A61K47/32;A61K47/38;A61P1/18;A61P9/12;A61P11/00;A61P11/06;A61P17/02;A61P35/00;(IPC1-7):A61K31/41;C07D257/02;A61P43/00 |
主分类号 |
A61K9/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
